EUSRA for EUS-guided RFA treatment - Reimbursement in Belgium from April 2024
02/04/2024
EUSRA, a feasible and safe ablative treatment for locally unresectable non-functional and functional pancreatic neuroendocrine tumors, is reimbursed in Belgium from the 1st of April 2024.